Capital Fund Management (CFM)’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-196,543	Closed	-$2.13M	–	2130
2024 Q2	$2.13M	Buy	196,543 +63,391	+48%	+$812K	0.01%	1354
2024 Q1	$2.5M	Buy	133,152 +60,246	+83%	+$1.39M	0.01%	1349
2023 Q4	$1.58M	Buy	72,906 +46,894	+180%	+$929K	﹤0.01%	1642
2023 Q3	$535K	Buy	26,012 +5,981	+30%	+$173K	﹤0.01%	1787
2023 Q2	$942K	Sell	20,031 -1,728	-8%	-$86K	﹤0.01%	1417
2023 Q1	$913K	Buy	21,759 +5,270	+32%	+$227K	﹤0.01%	1298
2022 Q4	$629K	Buy	16,489 +5,340	+48%	+$204K	﹤0.01%	1228
2022 Q3	$437K	Sell	11,149 -23,011	-67%	-$889K	﹤0.01%	1297
2022 Q2	$1.1M	Sell	34,160 -22,402	-40%	-$751K	0.01%	1042
2022 Q1	$1.87M	Sell	56,562 -19,761	-26%	-$743K	0.02%	978
2021 Q4	$3.25M	Buy	76,323 +10,649	+16%	+$446K	0.02%	814
2021 Q3	$2.91M	Buy	65,674 +12,363	+23%	+$567K	0.02%	780
2021 Q2	$3.03M	Sell	53,311 -10,019	-16%	-$708K	0.02%	773
2021 Q1	$4.74M	Buy	63,330 +52,590	+490%	+$4.31M	0.05%	443
2020 Q4	$929K	Buy	+10,740	New	+$792K	0.01%	1011
2020 Q2	–	Sell	-16,161	Closed	-$587K	–	1494
2020 Q1	$464K	Buy	+16,161	New	+$936K	0.01%	1052
2019 Q2	–	Sell	-1,297	Closed	-$206K	–	1878
2019 Q1	$206K	Buy	+1,297	New	+$188K	﹤0.01%	1583
2018 Q1	–	Sell	-3,065	Closed	-$505K	–	2138
2017 Q4	$505K	Buy	+3,065	New	+$297K	﹤0.01%	1444